[Efficacy of intravenous ceftazidime in childhood infections].
Ceftazidime, a beta-lactamase resistant cephalosporin, was administered intravenously to 33 patients with various infections. The age range was between 3 days and 15 years and substantial underlying disease was present in 90% of the patients and 72% had malignancy. Seventeen (51.5%) were in critical condition and twenty had granulocytopenia. Clinical and microbiological results were evaluated and overall clinical response was 88%. No major adverse effects were encountered. Ceftazidime was an effective and safe therapy for serious infections and neutropenic patients.
Kanra
G
G
Hacettepe Universitesi, Pediatri Anabilim Dali.
Gürsavaş
M
M
Aydin
M
M
Cengizlier
R
R
Seçmeer
G
G
Ceyhan
M
M
D000293:Adolescent; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy*; D002442:Ceftazidime / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007275:Injections, Intravenous; D008297:Male; D009503:Neutropenia / Q000150:complications*
D002442:Ceftazidime
Cocukluk çaği enfeksiyonlarinda intravenöz seftazidim'in etkinliği.